Sexual Dysfunction, Physiological
Welcome,         Profile    Billing    Logout  
 26 Companies   27 Products   27 Products   21 Mechanisms of Action   1 Trial   208 News 


12345»
  • ||||||||||  lidocaine topical / Generic mfg.
    Phase classification, Enrollment change, Trial primary completion date:  Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) -  Sep 13, 2018   
    P=N/A,  N=108, Active, not recruiting, 
    Recruiting --> Completed | Trial completion date: Mar 2018 --> Jan 2017 | Trial primary completion date: Mar 2018 --> Dec 2016 Phase classification: P4 --> P=N/A | N=224 --> 108 | Trial primary completion date: Jul 2018 --> Mar 2018
  • ||||||||||  Phase classification, Enrollment change, Trial primary completion date:  Focal Therapy for Prostate Cancer Using HIFU (clinicaltrials.gov) -  Apr 20, 2018   
    P=N/A,  N=354, Recruiting, 
    Phase classification: P4 --> P=N/A | N=224 --> 108 | Trial primary completion date: Jul 2018 --> Mar 2018 Phase classification: P2 --> P=N/A | N=272 --> 354 | Trial primary completion date: Jun 2014 --> Dec 2028
  • ||||||||||  Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date:  PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (clinicaltrials.gov) -  Mar 20, 2018   
    P4,  N=19, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=284 --> 19 | Trial completion date: Oct 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Dec 2017
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Enrollment change, Trial termination:  A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation (clinicaltrials.gov) -  Sep 20, 2017   
    P2,  N=59, Terminated, 
    N=74 --> 59 | Recruiting --> Terminated; Strategic business decision was made to terminate the program. There were no safety concerns.
  • ||||||||||  Phase classification, Enrollment change, Trial withdrawal:  HIM-UP: Health Interventions in Men Undergoing Radical Prostatectomy (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: May 2017 --> May 2018 Phase classification: P3 --> P=N/A | N=125 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Trial completion, Trial primary completion date:  Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) -  Oct 11, 2016   
    P=N/A,  N=173, Completed, 
    Active, not recruiting --> Completed | N=80 --> 2 Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Sep 2016
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Enrollment change, Trial primary completion date:  A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation (clinicaltrials.gov) -  Oct 5, 2016   
    P2,  N=74, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Sep 2016 N=60 --> 74 | Trial primary completion date: Oct 2016 --> Oct 2017
  • ||||||||||  Trial primary completion date:  Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) -  Feb 24, 2016   
    P=N/A,  N=200, Recruiting, 
    Trial primary completion date: Jan 2016 --> Oct 2016 Trial primary completion date: Dec 2015 --> Mar 2017
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Erectile Dysfunction in Severe Obstructive Sleep Apnea: Effects of CPAP Therapy (clinicaltrials.gov) -  Dec 5, 2015   
    P=N/A,  N=200, Completed, 
    Trial primary completion date: Sep 2013 --> Sep 2020 Active, not recruiting --> Completed | N=300 --> 200 | Trial primary completion date: May 2013 --> Dec 2015
  • ||||||||||  Biomarker, Enrollment closed, Enrollment change, Trial primary completion date:  HEART-MEND: Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes (clinicaltrials.gov) -  Nov 27, 2015   
    P=N/A,  N=568, Active, not recruiting, 
    Active, not recruiting --> Completed | N=300 --> 200 | Trial primary completion date: May 2013 --> Dec 2015 Recruiting --> Active, not recruiting | N=1143 --> 568 | Trial primary completion date: Jan 2015 --> May 2016
  • ||||||||||  sildenafil / Generic mfg.
    Trial completion, HEOR:  Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer (clinicaltrials.gov) -  Nov 16, 2015   
    P=N/A,  N=115, Completed, 
    Recruiting --> Active, not recruiting | N=1143 --> 568 | Trial primary completion date: Jan 2015 --> May 2016 Active, not recruiting --> Completed
  • ||||||||||  Cellgram-ED (autologous mesenchymal stem cell therapy) / Pharmicell
    Enrollment open, Trial initiation date:  Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction (clinicaltrials.gov) -  Aug 9, 2015   
    P1,  N=10, Recruiting, 
    Initiation date: Nov 2013 --> Sep 2015 | Trial primary completion date: Feb 2015 --> Sep 2016 Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jul 2015
  • ||||||||||  sildenafil / Generic mfg., testosterone gel / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Testosterone for Penile Rehabilitation After Radical Prostatectomy (clinicaltrials.gov) -  Jun 20, 2015   
    P0,  N=3, Terminated, 
    Not yet recruiting --> Completed | N=72 --> 42 N=24 --> 3 | Recruiting --> Terminated | Trial primary completion date: Nov 2012 --> Mar 2013; Lack of volunteers who would consent to participate and lack of funding
  • ||||||||||  sildenafil / Generic mfg.
    Trial completion:  Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer (clinicaltrials.gov) -  Jun 18, 2015   
    P4,  N=90, Completed, 
    N=24 --> 3 | Recruiting --> Terminated | Trial primary completion date: Nov 2012 --> Mar 2013; Lack of volunteers who would consent to participate and lack of funding Recruiting --> Completed